Substance Use During Pregnancy, Birth and the Postnatal Period

Ju Lee Oei, Syeda I. Azim, Evelyn Lee, Stacy L. Blythe, Kirsten I. Black, Valsamma Eapen, Nicholas Lintzeris, Karleen D. Gribble, Hannah G. Dahlen, Virginia Schmied, Adrian Dunlop, Raghu P. Lingam, Elizabeth Elliott, Ilan Katz, Lynn A. Kemp, Robyn L. Richmond, Deborah Schofield, Sara Clews, Lynette Bown, Keryl De HaanMelissa Jackson

Research output: Book/Research ReportResearch report

Abstract

Substance-use issues in pregnancy (SUP) are among the most preventable causes of poor pregnancy outcomes in the world. Based on the principles of Developmental Origins of Health and Disease, interventions and therapies to prevent and mitigate the effects of substance use in pregnancy are crucial to ameliorate the consequences of prenatal substance exposure. Preventing harm to the mother and her child, especially in the first 2000 days of life, requires interventions at many time points, as outlined in the framework for the NSW Ministry of Health’s policy for keeping families safe beyond the postnatal period. This Evidence Check was commissioned by the NSW Ministry of Health to gather and summarise the latest available evidence for the intervention and treatment of substance use during pregnancy, birth and the postnatal period with reference to four specific questions. The information gathered in this review will be used to update the 2014 NSW Health Clinical Guidelines for the Management of Substance Use during Pregnancy, Birth and the Postnatal Period.
Original languageEnglish
Place of PublicationGlebe, N.S.W.
PublisherSax Institute
Number of pages159
Publication statusPublished - 2021

Fingerprint

Dive into the research topics of 'Substance Use During Pregnancy, Birth and the Postnatal Period'. Together they form a unique fingerprint.

Cite this